Patent details

Basic Information

Publication number:

EP3080270

PCT Application Number:

US2014069951

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP148246606

PCT Publication Number:

WO2015089368

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

COMPLEMENT COMPONENT IRNA COMPOSITIONS AND METHODS OF USE THEREOF

French Title of Invention:

COMPOSITION D'ARNI D'ÉLÉMENT DE COMPLÉMENT ET PROCÉDÉS POUR LES UTILISER

German Title of Invention:

KOMPLEMENTKOMPONENTEN-IRNA-ZUSAMMENSETZUNGEN UND VERFAHREN ZUR VERWENDUNG DAVON

SPC Number:

Dates

Filing date:

04/09/2009

Grant date:

27/10/2021

EP Publication Date:

19/10/2016

PCT Publication Date:

18/06/2015

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

27/10/2021

EP B1 Publication Date:

27/10/2021

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

12/12/2021

Expiration date:

12/12/2034

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

20/10/2021

 

 

Name:

Alnylam Pharmaceuticals, Inc.

Address:

300 Third Street, 3rd Floor, Cambridge, MA 02142, United States (US)

Inventor

1

Name:

BORODOVSKY, Anna

Address:

United States (US)

2

Name:

BETTENCOURT, Brian

Address:

United States (US)

Priority

Priority Number:

201361915210 P

Priority Date:

12/12/2013

Priority Country:

United States (US)

Classification

IPC classification:

C12N 15/113; C12N 15/11; A61K 31/713; A61K 38/12; A61P 37/06; A61P 43/00; A61P 25/28;

Publication

European Patent Bulletin

Issue number:

202143

Publication date:

27/10/2021

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages